Midterm outcomes of laparoscopic sleeve gastrectomy as a stand-alone procedure in super-obese patients

Hong, Jamin; Menzo, Emanuele Lo; Rosenthal, Raúl J.

doi:10.1016/j.soard.2017.11.021

Cited by 24 publications

(10 citation statements)

References 34 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…A single-institution series demonstrated the safety and efficacy of bariatric surgery to treat patients with BMI > 50 kg/m 2 [ 31 ]. In some studies, SG and RYGB were comparable at 3-year follow-up [ 32 ], whereas others reported better results for RYGB at 1- and 2-year follow-up compared to SG [ 33 ], and OAGB at 1 year was more effective than SG [ 34 ]. Bhandari et al reported their experience in India in a retrospective study with 3-year follow-up.…”

Section: Discussionmentioning

confidence: 99%

Is One Anastomosis Gastric Bypass with a Biliopancreatic Limb of 150 cm Effective in the Treatment of People with Severe Obesity with BMI > 50?

et al. 2021

View full text Add to dashboard Cite

Purpose The treatment of people with severe obesity and BMI > 50 kg/m2 is challenging. The present study aims to evaluate the short and mid-term outcomes of one anastomosis gastric bypass (OAGB) with a biliopancreatic limb of 150 cm as a primary bariatric procedure to treat those people in a referral center for bariatric surgery. Material and Methods Data of patients who underwent OAGB for severe obesity with BMI > 50 kg/m2 between 2010 and 2017 were collected prospectively and analyzed retrospectively. Follow-up comprised clinical and biochemical assessment at 1, 3, 6, 12, 18, and 24 months postoperatively, and once a year thereafter. Results Overall, 245 patients underwent OAGB. Postoperative mortality was null, and early morbidity was observed in 14 (5.7%) patients. At 24 months, the percentage total weight loss (%TWL) was 43.2 ± 9, and percentage excess weight loss (%EWL) was 80 ± 15.7 (184 patients). At 60 months, %TWL was 41.9 ± 10.2, and %EWL was 78.1 ± 18.3 (79 patients). Conversion to Roux-en-Y gastric bypass was needed in three (1.2%) patients for reflux resistant to medical treatment. Six patients (2.4%) had reoperation for an internal hernia during follow-up. Anastomotic ulcers occurred in three (1.2%) patients. Only two patients (0.8%) underwent a second bariatric surgery for insufficient weight loss. Conclusion OAGB with a biliopancreatic limb of 150 cm is feasible and associated with sustained weight loss in the treatment of severe obesity with BMI > 50 kg/m2. Further randomized studies are needed to compare OAGB with other bariatric procedures in this setting. Graphical abstract

show abstract

Section: Discussionmentioning

confidence: 99%

Is One Anastomosis Gastric Bypass with a Biliopancreatic Limb of 150 cm Effective in the Treatment of People with Severe Obesity with BMI > 50?

et al. 2021

View full text Add to dashboard Cite

show abstract

“…There are a limited number of studies with up to 5-year outcomes that have focused on the outcomes of higher risk and/or super obese patients who underwent SG, many with the plan of second stage definitive procedure to follow. These studies were either retrospective (16), without comparison group (16), unmatched (17–19) or had lacked long-term follow up (17–19). Even so, the reported weight change, weight change comparison and obesity-related comorbidity improvement outcomes are similar, for the most part, to this LABS-2 report.…”

Section: Discussionmentioning

confidence: 99%

“…Thereaux et al in a single site study identified 74 SG (mean BMI 57.2 kg/m 2 ) and 285 RYGB (mean BMI 56.7 kg/m 2 ) patients and compared weight change and DM improvement at one year; RYGB demonstrated better weight loss and resolution of DM (17). Most recently, Hong et al in a retrospective study identified 106 SG with 501 RYGB patients with a preoperative BMI greater than 50 kg/m 2 with follow up to 3 years (19). There was not a statistically significant difference between procedures in the weight loss or rate of type 2 DM remission at any point in the 3-year follow up period.…”

Section: Discussionmentioning

confidence: 99%

Long-term weight change and health outcomes for sleeve gastrectomy (SG) and matched Roux-en-Y gastric bypass (RYGB) participants in the Longitudinal Assessment of Bariatric Surgery (LABS) study

Ahmed

King

Gourash

et al. 2018

Surgery

View full text Add to dashboard Cite

show abstract

“…SG was developed as the rst stage of a 2-stage bariatric surgical procedure especially for the super obese patient group with BMI≥50 (20,21). The consequent studies proved that SG on its own was also an effective bariatric surgical procedure (8,22,23). Some studies performed showed that SG provided more weight loss and caused less development of insulin sensitivity as compared to RYGB (24,25).…”

Section: Discussionmentioning

confidence: 99%

What is The Effect of Sleeve Gastrectomy in Patients with a BMI ≥ 50 kg/m2?

Ozturk

Çelik

2021

Preprint

View full text Add to dashboard Cite

Background: To investigate the effect of Sleeve Gastrectomy (SG) in patient with a Body Mass Index (BMI)≥50 kg/m² groups on weight loss and comorbidities as the first and alone option. Methods: The prospectively maintained data obtained from patients with a BMI ≥ 50 who underwent SG between February, 2016 - February, 2020 were evaluated. Results: 138 patient with a BMI≥50 kg/m² underwent surgery. Average BMI: 56.36±7.661, age 37.41±12.33. Forty eight patients underwent cholecystectomy and/or hiatal hernia repair (HHR), as well. The percentage of excess weight loss (%EWL) values of patients in months 3, 6, 12 and 24 were 36.70%, 54.34%, 67.58%, 72.45%, 74.14% and the percentage of total weight loss (TWL%) values were 20.17%, 29.59%, 36.93%, 39.62%, 40.65%, respectively. The mean BMI values in month 0 and in the 3rd, 6th, 12th, 18th, 24th months were 56.36, 45.10, 39.76, 35.48, 33.96 and 33.42 respectively. The values measured in the month 0 and in the 3rd, 6th, 12th, 18th, 24th months were significantly different for EWL%, TWL% and BMI variables (p<0.001), but EWL% (p = 0.527), TWL% (p = 0.396) and BMI (p=0.657) were not found significantly different between the 18th and 24th months. When EWL% was accepted as ≥50, the success rate was found to be 93.55%(n=93) and 92%(n=50) in months 12 and 24, respectively. Conclusion: SG appears to be an effective and safe treatment method as the first option for weight loss and for treatment of concomitant disorders in patient with a BMI ≥ 50 kg/m² groups. Further long-term studies are needed to confirm these results.

show abstract

Midterm outcomes of laparoscopic sleeve gastrectomy as a stand-alone procedure in super-obese patients

Cited by 24 publications

References 34 publications

Is One Anastomosis Gastric Bypass with a Biliopancreatic Limb of 150 cm Effective in the Treatment of People with Severe Obesity with BMI > 50?

Is One Anastomosis Gastric Bypass with a Biliopancreatic Limb of 150 cm Effective in the Treatment of People with Severe Obesity with BMI > 50?

Long-term weight change and health outcomes for sleeve gastrectomy (SG) and matched Roux-en-Y gastric bypass (RYGB) participants in the Longitudinal Assessment of Bariatric Surgery (LABS) study

What is The Effect of Sleeve Gastrectomy in Patients with a BMI ≥ 50 kg/m2?

Contact Info

Product

Resources

About